# Jeremy Levin

Лучшие выпуски подкастов
Обновлено:

China is Becoming the Bio-Tech Leader. The US Needs to Rethink National Strategy.

The majority of active pharmaceutical ingredients come from other countries. Whose responsibility is it to secure America’s future in healthcare innovation? Dr. Jeremy Levin is clear: everyone.

Ep. 116 - Ovid's Jeremy Levin on biotech in the balance

Throughout his career, which has included serving as president and CEO of Teva, chair of BIO, and a leader or senior executive of large and small biopharma companies, Jeremy Levin has challenged the industry to live up to its ideals. In an interview with BioCentury Washington Editor Steve Usdin, Le…

Betting on Biotech: Dr. Jeremy Levin's Playbook | How America Makes Medicine Ep. 4

🇺🇸 Why does so much pharmaceutical innovation come from small biotech companies? And how do different parts of America's medicine ecosystem work together to turn scientific discoveries into medicines for patients?In this episode of How America Makes Medicine, John Stanford sits down with Dr. Jeremy…

Rural Trauma Part II: Life at a Level III Center

In the first rural trauma episode, we examined the landscape from 30,000 feet, the definitions, the data gaps, the transfer challenges, and the system-level solutions. This episode gets on the ground. Host Dr. Caroline Park and co-moderator Dr. Jeremy Levin sit down with Dr. Whitney Selph, a genera…

Where Biotech Money Goes When Venture Capital Stops | Sara Jane Demy & Jeremy Levin

The A, B, C round path that funded biotech for thirty years is not currently available. Sara Jane Demy has just come out of her own Biotech CEO Summit, where that was the main topic. Jeremy Levin, who ran Teva Pharmaceutical Industries and sat on the executive committee at Bristol-Myers Squibb, has…

Made From Mistakes | Trust Is Built Through Transparency

In today’s episode, I sit down with three leaders bringing clarity, compassion, and possibility to their industries. Dr. Jeremy Levin explains the growing distrust surrounding biotechnology, the hidden forces driving medicine costs, and how patient-centered incentives can restore confidence. John P…

Jeremy Levin Discusses the Future of Biotech

As a physician, scientist, entrepreneur, and biotech CEO, Jeremy Levin has spent his career helping bring innovative medicines to patients. In his book, Biotech in the Balance, he argues that the future of healthcare depends on restoring trust in science, strengthening innovation, and keeping patie…

Putting Your Neck on the Line with Jeremy Levin_e.092

In this episode of Lab Rats to Unicorns, John Flavin sits down with Dr. Jeremy Levin, a physician, scientist, biotech executive, and longtime leader in the pharmaceutical industry. Jeremy has held senior roles across Genzyme, Novartis, Bristol-Myers Squibb, and Teva, and today serves as Executive C…

A Leadership Call to Action for Biotech

In this episode of Leading Edge with Ken Banta, Jeremy Levin, D.Phil, MB BChir, co-founder and executive chairman of Ovid Therapeutics, joins Banta, The Vanguard Network founder and CEO, for a wide-ranging and candid discussion on the challenges confronting the U.S. biotechnology industry and th…

Dr. Jeremy Levin - Is Trump’s drug pricing plan working?

Prescription drug prices continue to rise despite promises to lower costs for American families. Are recent reforms creating real change or mostly political headlines? Dr. Jeremy Levin is a biotech industry veteran and author of the upcoming book “Biotech in the Balance.” He joins the show to discu…